{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:08:37Z","timestamp":1786118917199,"version":"build-2736575974"},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T00:00:00Z","timestamp":1773705600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1097\/ms9.0000000000003256","type":"journal-article","created":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T15:03:34Z","timestamp":1743779014000},"page":"2468-2470","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Enhancing oncolytic reovirus therapy with proteasome inhibitors in multiple myeloma"],"prefix":"10.1097","volume":"88","author":[{"given":"Muhammad Rayan","family":"Aleem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khushbakht","family":"Baloch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minahil","family":"Shahid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sk. Sany","family":"Talha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,3,17]]},"reference":[{"key":"R1-20260402","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1002\/ajh.26590","article-title":"Multiple myeloma: 2022 update on diagnosis, risk stratification, and management","volume":"97","author":"Rajkumar","year":"2022","journal-title":"Am J Hematol"},{"key":"R2-20260402","doi-asserted-by":"crossref","first-page":"4919","DOI":"10.3390\/cancers14194919","article-title":"Second primary malignancy risk in multiple myeloma from 1975 to 2018","volume":"14","author":"Wang","year":"2022","journal-title":"Cancers (Basel)"},{"key":"R3-20260402","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.3390\/cancers3033279","article-title":"Assessment of the evolution of cancer treatment therapies","volume":"3","author":"Arruebo","year":"2011","journal-title":"Cancers (Basel)"},{"key":"R4-20260402","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.3390\/cancers13112761","article-title":"Oncolytic viruses in combination therapeutic approaches with epigenetic modulators: past, present, and future perspectives","volume":"13","author":"Chianese","year":"2021","journal-title":"Cancers (Basel)"},{"key":"R5-20260402","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1111\/cas.13027","article-title":"Oncolytic virus therapy: a new era of cancer treatment at dawn","volume":"107","author":"Fukuhara","year":"2016","journal-title":"Cancer Sci"},{"key":"R6-20260402","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/s41392-023-01407-6","article-title":"Oncolytic virotherapy: basic principles, recent advances and future directions","volume":"8","author":"Lin","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"R7-20260402","doi-asserted-by":"crossref","first-page":"229","DOI":"10.5501\/wjv.v10.i5.229","article-title":"Oncolytic virus therapy in cancer: a current review","volume":"10","author":"Santos Apolonio","year":"2021","journal-title":"World J Virol"},{"key":"R8-20260402","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1146\/annurev-pharmtox-010919-023603","article-title":"Proteasome inhibitor drugs","volume":"60","author":"Fricker","year":"2020","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"R9-20260402","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3390\/cancers12020265","article-title":"Proteasome inhibitors for the treatment of multiple myeloma","volume":"12","author":"Ito","year":"2020","journal-title":"Cancers (Basel)"},{"key":"R10-20260402","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3390\/v8010009","article-title":"Overcoming barriers in oncolytic virotherapy with HDAC inhibitors and immune checkpoint blockade","volume":"8","author":"Marchini","year":"2016","journal-title":"Viruses"},{"key":"R11-20260402","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13045-024-01645-3","article-title":"Proteasome inhibition enhances oncolytic reovirus therapy in multiple myeloma independently of its direct cytotoxic effects","volume":"18","author":"Dona","year":"2025","journal-title":"J Hematol Oncol"},{"key":"R12-20260402","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.3390\/ijms24031823","article-title":"Role of NF-\u03baB signaling in the interplay between multiple myeloma and mesenchymal stromal cells","volume":"24","author":"Cippitelli","year":"2023","journal-title":"Int J Mol Sci"}],"container-title":["Annals of Medicine &amp; Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MS9.0000000000003256","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:07:55Z","timestamp":1786036075000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MS9.0000000000003256"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,17]]},"references-count":12,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/ms9.0000000000003256","relation":{},"ISSN":["2049-0801"],"issn-type":[{"value":"2049-0801","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,17]]},"assertion":[{"value":"2025-03-04","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-03-21","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}